MMP-9 inhibitors (MMPIs) are considered metastasis deterrents and anti-angiogenic agents for colorectal cancer, and have also been proved to inhibit pre-cancerous states like colitis and other inflammatory bowel diseases [40]. This evidence concerns the gene MMP9 and colorectal cancer.